Profile of alectinib for the treatment of ALK-positive non-small cell lung cancer (NSCLC): patient selection and perspectives

Karachaliou N, Fernandez Bruno M, Bracht JWP, Rosell R

OncoTargets and Therapy 2019, 12:4567-4575

Published Date: 13 June 2019